ICER's report on sickle cell disease🧪 is out today! Current evidence suggests that lovo-cel and exa-cel would achieve common thresholds for cost-effectiveness if priced between $1.35M to $2.05M #healthpolicy - ThreadSky

dmitriy.bsky.social • 599 days ago

ICER's report on sickle cell disease🧪 is out today!

Current evidence suggests that lovo-cel and exa-cel would achieve common thresholds for cost-effectiveness if priced between $1.35M to $2.05M

#healthpolicy